What are the clinical features of immunoglobulin G4‑related disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Features of IgG4-Related Disease

IgG4-related disease (IgG4-RD) is a multisystem fibroinflammatory disorder that can affect virtually any organ, most commonly presenting with pancreatic involvement (autoimmune pancreatitis), biliary tract disease (sclerosing cholangitis), and salivary/lacrimal gland enlargement, often with elevated serum IgG4 levels and characteristic histopathological findings. 1

Organ Involvement Patterns

Most Commonly Affected Organs

The disease demonstrates a predilection for specific organ systems 1, 2, 3:

  • Salivary glands - most frequently involved
  • Lacrimal glands - second most common
  • Lymph nodes - widespread involvement possible
  • Pancreas (type 1 autoimmune pancreatitis/IgG4-RP) - 38-42% of cases
  • Biliary tract (IgG4-SC) - can occur in 59% of IgG4-RD patients
  • Kidneys - typically interstitial nephritis (33% of cases)
  • Retroperitoneum/periaorta - retroperitoneal fibrosis
  • Lungs - interstitial disease or nodules

Multiorgan Involvement

Approximately 47-51% of patients have multiple organ involvement at diagnosis, with a mean of 3.2 organs affected 3, 4. Patients with serum IgG4 levels ≥5× upper limit of normal (ULN) demonstrate significantly higher rates of multiorgan involvement compared to those with lower levels 5.

Clinical Presentation

Symptomatic Manifestations

The clinical presentation varies dramatically by organ involvement 1:

Biliary/Pancreatic Disease:

  • Obstructive jaundice - 77% of IgG4-SC patients present with jaundice
  • Abdominal pain - common presenting symptom
  • Pancreatic mass or diffuse enlargement on imaging
  • 91% of jaundiced patients have concurrent IgG4-related pancreatitis

Glandular Disease:

  • Salivary gland swelling (Mikulicz's disease pattern)
  • Lacrimal gland enlargement
  • Often bilateral and symmetric

Systemic Features:

  • Lymphadenopathy - frequent finding
  • Generally low inflammatory markers despite active disease

Asymptomatic Presentation

A notable proportion of patients, particularly those with renal or retroperitoneal involvement, are diagnosed incidentally during evaluation for other conditions 6. This contrasts with more symptomatic presentations in pancreatic or biliary disease.

Laboratory Features

Serum IgG4 Levels

Elevated serum IgG4 is found in 50-85.7% of patients, though this varies by population 1, 3, 4:

  • Mean serum IgG4 level approximately 755 mg/dL in Japanese cohorts
  • Serum IgG4 >4× ULN is highly specific for IgG4-SC versus PSC 1
  • IgG4/IgG1 ratio >0.24 improves diagnostic specificity 1
  • Important caveat: Elevated IgG4 alone is insufficient for diagnosis, as 9-15% of PSC patients also have elevated levels 1

Other Laboratory Abnormalities

Key laboratory findings include 3, 4, 6:

  • Hypocomplementemia - low C3 in 34.7-37.5% of patients, low C4 in 12.2%
    • Particularly common in kidney involvement - all patients with renal disease showed hypocomplementemia in one study 4
    • Inverse correlation between C3 and non-IgG4 IgG levels in kidney lesions 3
  • Eosinophilia - more frequent in renal involvement 6
  • Low CRP - median 0.1 mg/dL, with 90% having levels <1 mg/dL 3
  • Polyclonal gammopathy
  • Elevated total IgG levels (correlates with IgG4 levels)

Correlation with Disease Extent

Serum IgG4 levels positively correlate with 5, 4:

  • Number of organs involved
  • Total protein and globulin levels
  • IgG4/IgG ratio

Negative correlations exist with:

  • Serum albumin levels
  • Complement C3 levels

Histopathological Features

Characteristic Triad

All affected tissues demonstrate similar pathological findings 1:

  1. Dense lymphoplasmacytic infiltrate with IgG4-positive plasma cells
  2. Storiform fibrosis - characteristic whorled pattern
  3. Obliterative phlebitis - inflammation and occlusion of veins

Diagnostic Thresholds

>10 IgG4-positive plasma cells per high-power field in biopsy specimens supports diagnosis 1

  • IgG4+/IgG+ plasma cell ratio >40% provides additional histological evidence 1
  • Ampullary biopsy shows IgG4-positive infiltration in 53-80% of IgG4-related pancreatitis 1

Imaging Characteristics

Cross-Sectional Imaging Findings

CT and MRI/MRCP reveal organ-specific patterns 1:

Pancreatic:

  • Diffuse enlargement or focal mass ("sausage-shaped" pancreas)
  • Long pancreatic duct stricture (>1/3 of main duct length)
  • Multifocal stricturing without upstream dilatation

Biliary (IgG4-SC) - Four Types:

  • Type 1: Intrapancreatic bile duct stenosis
  • Type 2a: Intrahepatic stenosis with prestenotic dilatation
  • Type 2b: Intrahepatic stenosis with peripheral pruning
  • Type 3: Hilar and lower common bile duct stenosis
  • Type 4: Hilar stenosis only

Key distinguishing features from PSC:

  • Long strictures with prestenotic dilatations
  • Absence of peripheral duct pruning
  • Lack of biliary pseudodiverticulae

PET Imaging

FDG-PET can identify multisystem involvement by detecting uptake in salivary glands, lacrimal glands, and other distant sites, reinforcing diagnostic suspicion 1.

Disease Course and Prognosis

Natural History

The disease course is variable 1:

  • Generally indolent in many patients (median follow-up 4 years in large cohort)
  • Risk of progression to cirrhosis: 7.7-9% of patients
  • Liver transplantation required in some cases
  • Increased morbidity, malignancy, and mortality compared to age-matched controls 1

Response to Treatment

A hallmark feature is prompt clinical and radiographic response to corticosteroids 1:

  • >90% achieve remission with initial glucocorticoid therapy 7
  • 73-84.2% show complete or partial remission 4, 8
  • Relapse occurs in >40% of cases after initial response 1

Demographic Features

Age and Sex Distribution

  • Median age at diagnosis: 59-65 years - predominantly middle-aged to elderly 3, 8
  • Male predominance: 76.2-76.8% of cases 3, 8
  • Older patients more common in renal and retroperitoneal involvement 6

Key Diagnostic Pitfalls

Mimicking Conditions

IgG4-RD can masquerade as malignancy, particularly:

  • Cholangiocarcinoma (CCA) - up to 8% of presumed hilar CCA cases are actually IgG4-SC 1
  • Pancreatic cancer
  • Lymphoma

Overlap with Other Diseases

Low prevalence of inflammatory bowel disease (5.6%) distinguishes IgG4-SC from PSC (70% IBD association) 1

Laboratory Limitations

  • Elevated IgG4 is supportive but not diagnostic - cannot distinguish IgG4-SC from PSC alone 1
  • Brush cytology insufficient for definitive diagnosis 1
  • Core biopsy preferred over fine-needle aspiration for pathological confirmation 1

Population Differences

Important variation exists between Japanese and Western populations 3:

  • Japanese patients: consistently low CRP, very high rates of elevated IgG4 (>95%)
  • Western patients: may show different inflammatory marker patterns
  • These differences may require consideration in international diagnostic criteria development

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.